Platelet reactivity evaluated with the VASP assay following ticagrelor loading dose in acute coronary syndrome patients undergoing percutaneous coronary intervention

Thrombosis Research

Volumn 132, Issue 1, 2013, Pages

  Laine, Marc ^a   Toesca, Richard ^b   Berbis, Julie ^c   Frere, Corinne ^d   Barnay, Pierre ^e   Pansieri, Michel ^e   Peyre, Jean Pascal ^f   Michelet, Pierre ^b   Bessereau, Jacques ^b   Camilleri, Elise ^g   Helaf, Olfa ^a   Camaleonte, Marjorie ^a   Paganelli, Franck ^a   Dignat George, Françoise ^d   Bonello, Laurent ^a,d  

^a HÔPITAL NORD   (France)

^b TIMONE HOSPITAL   (France)

^c AIX MARSEILLE UNIVERSITY   (France)

^d INSERM   (France)

^e Service de Cardiologie   (France)

^f Service Urgence SMUR UHCD Centre hospitalier de Montbrison   (France)

^g Hôpital de Martigues   (France)

Author keywords

Acute coronary syndromes; On treatment platelet reactivity; P2Y12 ADP receptor antagonist; Ticagrelor; VASP index

Indexed keywords

ACETYLSALICYLIC ACID; CREATININE; CYTOCHROME P450 3A4; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PROSTAGLANDIN E1; PROTON PUMP INHIBITOR; PURINERGIC P2Y12 RECEPTOR; TICAGRELOR; VASODILATOR STIMULATED PHOSPHOPROTEIN;

ACUTE CORONARY SYNDROME; ADULT; ARTICLE; CORONARY STENT; DRUG ELUTING STENT; FEMALE; HUMAN; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; OBSERVATIONAL STUDY; PERCUTANEOUS CORONARY INTERVENTION; PLATELET REACTIVITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; UNSTABLE ANGINA PECTORIS;

ACS; ACUTE CORONARY SYNDROME; ACUTE CORONARY SYNDROMES; HIGH ON-TREATMENT PLATELET REACTIVITY; HTPR; LD; LOADING DOSE; LOW ON-TREATMENT PLATELET REACTIVITY; LTPR; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; NSTEMI; ON-TREATMENT PLATELET REACTIVITY; P2Y12-ADP RECEPTOR ANTAGONIST; PCI; PERCUTANEOUS CORONARY INTERVENTION; PLATELET REACTIVITY; PR; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STEMI; TICAGRELOR; VASODILATOR-STIMULATED PHOSPHOPROTEIN; VASP; VASP INDEX;

ACUTE CORONARY SYNDROME; ADENOSINE; AGED; BLOOD PLATELETS; FEMALE; HUMANS; MALE; MIDDLE AGED; PERCUTANEOUS CORONARY INTERVENTION; PLATELET ACTIVATION; PROSPECTIVE STUDIES; PURINERGIC P2 RECEPTOR ANTAGONISTS;

EID: 84881310097     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2013.04.030     Document Type: Article

References (28)

1. S.R. Mehta, S. Yusuf, R.J. Peters, M.E. Bertrand, B.S. Lewis, and M.K. Natarajan Clopidogrel in Unstable angina to prevent Recurrent Events trial (CURE) Investigators. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study Lancet 358 2001 527 533 (Pubitemid 32772726)
2. A. Schömig, F.J. Neumann, A. Kastrati, H. Schühlen, R. Blasini, and M. Hadamitzky A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents N Engl J Med 334 1996 1084 1089 (Pubitemid 26120185)
3. W. Hochholzer, D. Trenk, D. Frundi, P. Blanke, B. Fischer, and K. Andris Time dependence of platelet inhibition after a 600-mg loading dose of clopidogrel in a large, unselected cohort of candidates for percutaneous coronary intervention Circulation 111 2005 2560 2564 (Pubitemid 40740853)
4. P. Järemo, T.L. Lindahl, S.G. Fransson, and A. Richter Individual variations of platelet inhibition after loading doses of clopidogrel J Intern Med 252 2002 233 238
5. L. Bonello, U.S. Tantry, R. Marcucci, R. Blindt, D.J. Angiolillo, and R. Becker Consensus and future directions on the definition of high on-treatment platelet reactivity to adenosine diphosphate J Am Coll Cardiol 56 2010 919 933
6. D. Aradi, A. Komócsi, A. Vorobcsuk, O. Rideg, M. Tokés-Füzesi, and T. Magyarlaki Prognostic significance of high on-clopidogrel platelet reactivity after percutaneous coronary intervention: Systematic review and meta-analysis Am Heart J 160 2010 543 551
7. P.A. Gurbel, K.P. Bliden, K. Butler, U.S. Tantry, T. Gesheff, and C. Wei Randomized double-blind assessment of the ONSET and OFFSET of the antiplatelet effects of ticagrelor versus clopidogrel in patients with stable coronary artery disease: the ONSET/OFFSET study Circulation 120 2009 2577 2585
8. L. Wallentin, R.C. Becker, A. Budaj, C.P. Cannon, H. Emanuelsson, and C. Held Ticagrelor versus clopidogrel in patients with acute coronary syndromes N Engl J Med 361 2009 1045 1057
9. C.P. Cannon, R.A. Harrington, S. James, D. Ardissino, R.C. Becker, and H. Emanuelsson PLATelet inhibition and patient Outcomes Investigators. Comparison of ticagrelor with clopidogrel in patients with a planned invasive strategy for acute coronary syndromes (PLATO): a randomised double-blind study Lancet 375 2010 283 293
10. D. Sibbing, S. Schulz, S. Braun, T. Morath, J. Stegherr, and J. Mehilli Antiplatelet effects of clopidogrel and bleeding in patients undergoing coronary stent placement J Thromb Haemost 8 2010 250 256
11. L. Bonello, J. Mancini, M. Pansieri, L. Maillard, P. Rossi, and F. Collet Relationship between post-treatment platelet reactivity and ischemic and bleeding events at 1-year follow-up in patients receiving prasugrel J Thromb Haemost 10 2012 1999 2005
12. ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC) Eur Heart J 32 2011 2999 3054
13. R.F. Storey, D.J. Angiolillo, S.B. Patil, B. Desai, R. Ecob, and S. Husted Inhibitory effects of ticagrelor compared with clopidogrel on platelet function in patients with acute coronary syndromes: the PLATO (PLATelet inhibition and patient Outcomes) PLATELET substudy J Am Coll Cardiol 56 2010 1456 1462
14. D. Alexopoulos, I. Xanthopoulou, V. Gkizas, G. Kassimis, K.C. Theodoropoulos, and G. Makris Randomized Assessment of Ticagrelor Versus Prasugrel Antiplatelet Effects in Patients with ST-Segment-Elevation Myocardial Infarction Circ Cardiovasc Interv 5 2012 797 804
15. D. Alexopoulos, A. Galati, I. Xanthopoulou, E. Mavronasiou, G. Kassimis, and K.C. Theodoropoulos Ticagrelor versus prasugrel in acute coronary syndrome patients with high on-clopidogrel platelet reactivity following percutaneous coronary intervention: a pharmacodynamic study J Am Coll Cardiol 60 2012 193 199
16. L. Bonello, J. Berbis, M. Laine, S. Armero, J. Bessereau, and L. Jacquin Biological efficacy of a 600 mg loading dose of clopidogrel in ST-elevation myocardial infarction Thromb Haemost 108 2012 101 106
17. U.R. Schwarz, J. Geiger, U. Walter, and M. Eigenthaler Flow cytometry analysis of intracellular VASP phosphorylation for the assessment of activating and inhibitory signal transduction pathways in human platelets - definition and detection of ticlopidine/clopidogrel effects Thromb Haemost 82 1999 1145 1152 (Pubitemid 29419734)
18. H.J. Bouman, E. Parlak, J.W. van Werkum, N.J. Breet, H. ten Cate, and C.M. Hackeng Which platelet function test is suitable to monitor clopidogrel responsiveness? A pharmacokinetic analysis on the active metabolite of clopidogrel J Thromb Haemost 8 2010 482 488
19. H.M. Judge, R.J. Buckland, A. Sugidachi, J.A. Jakubowski, and R.F. Storey Relationship between degree of P2Y12 receptor blockade and inhibition of P2Y12-mediated platelet function Thromb Haemost 103 2010 1210 1217
20. L. Bonello, L. Camoin-Jau, S. Arques, C. Boyer, D. Panagides, and O. Wittenberg Adjusted clopidogrel loading doses according to vasodilator- stimulated phosphoprotein phosphorylation index decrease rate of major adverse cardiovascular events in patients with clopidogrel resistance: a multicenter randomized prospective study J Am Coll Cardiol 51 2008 1404 1411 (Pubitemid 351447314)
21. L. Bonello, L. Camoin-Jau, S. Armero, O. Com, S. Arques, and C. Burignat-Bonello Tailored clopidogrel loading dose according to platelet reactivity monitoring to prevent acute and subacute stent thrombosis Am J Cardiol 103 2009 5 10
22. S. El Ghannudi, P. Ohlmann, N. Meyer, M.L. Wiesel, B. Radulescu, and M. Chauvin Impact of P2Y12 inhibition by clopidogrel on cardiovascular mortality in unselected patients treated by percutaneous coronary angioplasty: a prospective registry JACC Cardiovasc Interv 3 2010 648 656
23. A.D. Michelson, A.L. Frelinger III, E. Braunwald, W.E. Downey, D.J. Angiolillo, and N.P. Xenopoulos TRITON-TIMI 38 Investigators. Pharmacodynamic assessment of platelet inhibition by prasugrel vs. clopidogrel in the TRITON-TIMI 38 trial Eur Heart J 30 2009 1753 1763
24. L. Bonello, M. Pansieri, J. Mancini, R. Bonello, L. Maillard, and P. Barnay High on-treatment platelet reactivity after prasugrel loading dose and cardiovascular events after percutaneous coronary intervention in acute coronary syndromes J Am Coll Cardiol 58 2011 467 473
25. F. Mangiacapra, G. Patti, E. Barbato, A.J. Peace, E. Ricottini, and V. Vizzi A therapeutic window for platelet reactivity for patients undergoing elective percutaneous coronary intervention: results of the ARMYDA-PROVE (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty-Platelet Reactivity for Outcome Validation Effort) study JACC Cardiovasc Interv 5 2012 281 289
26. O. Ait-Mokhtar, L. Bonello, S. Benamara, and F. Paganelli High on-treatment platelet reactivity Heart Lung Circ 21 2012 12 21
27. S. Guthikonda, C.L. Alviar, M. Vaduganathan, M. Arikan, A. Tellez, and T. DeLao Role of reticulated platelets and platelet size heterogeneity on platelet activity after dual antiplatelet therapy with aspirin and clopidogrel in patients with stable coronary artery disease J Am Coll Cardiol 52 2008 743 749
28. D. Alexopoulos, I. Xanthopoulou, P. Davlouros, G. Tsigkas, A. Damelou, and K.C. Theodoropoulos Pre-treatment platelet reactivity contribution to residual, post-treatment platelet reactivity in prasugrel and ticagrelor treated patients J Thromb Haemost 11 2013 381 384